Multivalvular Disease: Percutaneous Management in 2019 and Beyond
Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patien...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2019-11-01
|
| Series: | Interventional Cardiology: Reviews, Research, Resources |
| Online Access: | https://www.icrjournal.com/articles/Multivalvular-Disease-Percutaneous-Management-2019 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850110729315680256 |
|---|---|
| author | Magdalena Erlebach Rüdiger Lange |
| author_facet | Magdalena Erlebach Rüdiger Lange |
| author_sort | Magdalena Erlebach |
| collection | DOAJ |
| description | Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population. |
| format | Article |
| id | doaj-art-81d87deb3f12433da9dfc3a9365d8cfa |
| institution | OA Journals |
| issn | 1756-1477 1756-1485 |
| language | English |
| publishDate | 2019-11-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | Interventional Cardiology: Reviews, Research, Resources |
| spelling | doaj-art-81d87deb3f12433da9dfc3a9365d8cfa2025-08-20T02:37:46ZengRadcliffe Medical MediaInterventional Cardiology: Reviews, Research, Resources1756-14771756-14852019-11-0114314214610.15420/icr.2019.13.R1Multivalvular Disease: Percutaneous Management in 2019 and BeyondMagdalena Erlebach0Rüdiger Lange1Department of Cardiovascular Surgery, German Heart Centre, Munich, Germany; Institute of Translational Cardiac Surgery, Department of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, GermanyDepartment of Cardiovascular Surgery, German Heart Centre, Munich, Germany; Institute of Translational Cardiac Surgery, Department of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, GermanyPatients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population.https://www.icrjournal.com/articles/Multivalvular-Disease-Percutaneous-Management-2019 |
| spellingShingle | Magdalena Erlebach Rüdiger Lange Multivalvular Disease: Percutaneous Management in 2019 and Beyond Interventional Cardiology: Reviews, Research, Resources |
| title | Multivalvular Disease: Percutaneous Management in 2019 and Beyond |
| title_full | Multivalvular Disease: Percutaneous Management in 2019 and Beyond |
| title_fullStr | Multivalvular Disease: Percutaneous Management in 2019 and Beyond |
| title_full_unstemmed | Multivalvular Disease: Percutaneous Management in 2019 and Beyond |
| title_short | Multivalvular Disease: Percutaneous Management in 2019 and Beyond |
| title_sort | multivalvular disease percutaneous management in 2019 and beyond |
| url | https://www.icrjournal.com/articles/Multivalvular-Disease-Percutaneous-Management-2019 |
| work_keys_str_mv | AT magdalenaerlebach multivalvulardiseasepercutaneousmanagementin2019andbeyond AT rudigerlange multivalvulardiseasepercutaneousmanagementin2019andbeyond |